Limited Competition: Alzheimer's Disease Cooperative Study (U19)
Post Date
November 28th 2011
Application Due Date
March 7th 2012
Funding Opportunity Number
RFA-AG-13-001
CFDA Number(s)
93.866
Funding Instrument Type(s)
Cooperative Agreement
Funding Activity Categories
Eligibility Categories
Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Funding
-
Estimated Total Funding:
$13000000
-
Award Range:
$None - $None
Grant Description
This limited competition FOA is to continue the Alzheimer's Disease Cooperative Study (ADCS) as the pre-eminent Alzheimer's disease (AD) clinical trials consortium. The purpose of this FOA is to solicit the renewal application for the next 5-year cycle of the ADCS. The goals of this next phase are to continue to advance research in the development of interventions that might be useful for treating, delaying, or preventing AD, particularly interventions that might not be developed by industry.
Contact Information
-
Agency
Department of Health and Human Services
-
Office:
National Institutes of Health
-
Agency Contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV -
Agency Mailing Address:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
- Agency Email Address:
-
More Information:
http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-13-001.html
Get A Free Grant Assistance Kit
To start your application for a free grant package go to: